All News

T2T.RA_.jpg

Measureable Benefits to Treat-to-Target Management in RA

d Jack Cush, MD

Desai and colleagues have published that when a learning collaborative group focused on a treat‐to‐target approach was compared to usual care, a modest but significant impact on implementation, treatment changes and patient outcomes in RA patients managed with a treat‐to‐target approach was seen.

Read Article
lupus_0.jpg

Higher Lupus Mortality Among Minority Populations

d Jack Cush, MD

The February 19th MMWR reports that higher mortality rates in certain patients with systemic lupus erythematosus (SLE); data based on recent San Francisco County statistics showing a four fold higher mortality among Asian and Hispanic/Latina females with SLE.

Read Article
gout.MTP_.jpg

ANAGO Study - Anakinra for Gout Flare

d MedPage Today

The interleukin (IL)-1 receptor antagonist anakinra (Kineret) was not superior to triamcinolone for relieving gout flares, but had similar effects for pain reduction as the glucocorticoid, a randomized phase II study found.

Read Article
Psoriasis has greatest risk of MTX liver dz - a Danish Population study of PsO, PsA & RA pts taking MTX. Risk of liver Dz was most in PsO, followed by PsA, then RA. PsO had 1.6-3.4 fold risk (mild-severe) liver dz (vs RA). PsA was 1.3-1.6x higher) https://t.co/9YiGqVr66w

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - Periorbital Edema Dermatomyositis, Surprising Onset, Surprising Labs https://t.co/KhXm10HoNV https://t.co/eRl4zUYQbh

Links:

Dr. John Cush RheumNow ( View Tweet)
We are excited to share that Roy Fleischmann will be leading a discussion on future therapy in RA at RheumnNow Live next month. Sign up today to attend in person or virtually. https://t.co/vJlU0Z3Q3x https://t.co/uN1MrzWZA9

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: ANAGO Study - Anakinra for Gout Flare https://t.co/btP7ivMuPO https://t.co/HHsUKsjjuI

Links:

Dr. John Cush RheumNow ( View Tweet)
Other than anti-tRNA synthetase Abs, there are several new Abs associated with PM/DM @UTSWNews @UTSWInternalMed https://t.co/EttRB3YYHm
Dr. John Cush RheumNow ( View Tweet)
Classic path findings in dermatomyositis @UTSWNews @UTSWInternalMed https://t.co/W61OveDSwG
Dr. John Cush RheumNow ( View Tweet)
An unsual type of adult polymyositis that is not usually steroid responsive - Polymyositis with mitochondrial abnormalities - older patients +COX staining, slow progression. @UTSWNews @UTSWInternalMed https://t.co/2tv1R3e9Qg
Dr. John Cush RheumNow ( View Tweet)
Rheumatology Grand Rounds with Dr. Dennis Burns - lecturing on neuropathology of inflammatory myositis. Not all Muscle Bxs are positive, estimated sampling error w/ normal findings in 10-15% @UTSWNews @UTSWInternalMed https://t.co/Xm73GuMa3j
Dr. John Cush RheumNow ( View Tweet)
A woman w/ Raynauds, puffy fingers, nailfold capillary changes, abundant mat telangiectases consistent with limited cutaneous systemic sclerosis. Telangiectasias can be on skin, oral mucosa, GI tract & may associate w/ pulm HTN. https://t.co/FcL4VHMpmM

Links:

Dr. John Cush RheumNow ( View Tweet)

New Video: Dry Eyes and Tripping Over Tires RWCS 2021 Poster Session by Dr. Faizan Ahmad https://t.co/9UymYbYcJ0

Links:

Dr. John Cush RheumNow ( View Tweet)

Cohort analysis of 12351 RA patients from CPRD registry - finds RA on both glucorticoids & PPI have a greater risk OP fractures (adj HR: 1.60, 95% CI: 1.35 to 1.89) vs non-use. Higher than the Fx Risk with either oral GC or PPI use alone (adj HR 1.2). https://t.co/oPMnJoHCjX https://t.co/eW7rpVeHa4

Links:

Dr. John Cush RheumNow ( View Tweet)
Retrospective cohort study shows the risk of RA was lower in T2DM/diabetes (aHR 0.73; 95% CI 0.67–0.79) vs without T2DM. This risk was lost in when statins were not used (aHR 0.89; 0.69–1.14). Statins (in T2DM) had a protective effect against RA onset https://t.co/CfMJIuGOXI

Links:

Dr. John Cush RheumNow ( View Tweet)

These companies do autoinflammatory gene testing in the USA. @RWCSmtg https://t.co/KiJ1wbyihw
Dr. John Cush RheumNow ( View Tweet)
Have you registered for RheumNow Live yet? Attend 3/20-3/21 in Fort Worth, TX or virtually! https://t.co/uwxOVh142F https://t.co/DXZPp8wJkv

Links:

Dr. John Cush RheumNow ( View Tweet)
News Feature: Diagnosis & Treatment of Osteoarthritis Reviewed Katz, Arant and Loeser have published a comprehensive open-read overview of OA of the hip and knee in JAMA; underscoring the impact, advances, disappointments and guidelines put forth https://t.co/VVnUk02KiP https://t.co/97dFC56Jcb

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - PFAPA Syndrome Recurrent Fevers, Stomatitis, Lymphadenopathy ? https://t.co/uMBk8e2wJO https://t.co/LIs02svEDB

Links:

Dr. John Cush RheumNow ( View Tweet)
We are excited to announce that Jeff Sparks ( @jeffsparks) will be leading a discussion on ILD in RA at RheumNow Live this March. Register to attend today. https://t.co/uwxOVh142F https://t.co/bnittqkhKQ

Links:

Dr. John Cush RheumNow ( View Tweet)
×